Nurse Practitioner, Family · Torrington, CT
NPI
1699067314
Since 2011
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
780 Litchfield St
Torrington, CT, 06790
Phone (860) 496-2198
Groups this clinician bills Medicare through
Medicare paid, 2024
$33K
774 services
Medicare patients, 2024
250
Average age 72
Drug cost, 2024
$5.5M
7,718 prescriptions
Company payments, 2025
$4,387
From 30 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David J Ohotnicky was code 99214 (office e&m - established), 424 times for 224 patients. In total David J Ohotnicky billed 774 services in 6 codes, and Medicare paid $33K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-01-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 424 | 224 | $59.15 | $25K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 193 | 179 | $11.39 | $2,198 |
| 95251 Test - Miscellaneous | Facility | 113 | 64 | $21.32 | $2,409 |
| 99204 Office E&M - New | Facility | 22 | 22 | $89.70 | $1,973 |
| 99213 Office E&M - Established | Facility | 15 | 12 | $39.96 | $599 |
By year: 2022 $32K for 572 services; 2023 $32K for 584 services; 2024 $33K for 774 services.
Medicare prescription drug claims, 2024
In 2024, the drug David J Ohotnicky prescribed most often to Medicare patients was Ozempic (Semaglutide), with 676 prescriptions and refills. In total David J Ohotnicky wrote 7,718 Medicare prescriptions that cost $5.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 676 | 1,273 | 151 | $1.2M |
| Metformin Hcl Generic | 383 | 995 | 114 | $5,984 |
| Levothyroxine Sodium Generic | 345 | 939 | 113 | $3,677 |
| Jardiance Empagliflozin | 339 | 887 | 104 | $528K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 320 | 871 | 136 | $41K |
| Mounjaro Tirzepatide | 308 | 375 | 61 | $398K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 301 | 627 | 89 | $65K |
| Tresiba Flextouch U-200 Insulin Degludec | 290 | 731 | 88 | $318K |
| Trulicity Dulaglutide | 290 | 491 | 72 | $488K |
| Farxiga Dapagliflozin Propanediol | 255 | 560 | 60 | $316K |
| Novolog Flexpen Insulin Aspart | 208 | 376 | 65 | $50K |
| Tradjenta Linagliptin | 201 | 421 | 53 | $207K |
| Atorvastatin Calcium Generic | 196 | 545 | 57 | $1,727 |
| Humalog Kwikpen U-100 Insulin Lispro | 190 | 412 | 70 | $55K |
| Rosuvastatin Calcium Generic | 185 | 493 | 52 | $2,251 |
Brand drugs: 4,930 claims; generic drugs: 2,153 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David J Ohotnicky $4,387 ($4,387 in general payments such as food, travel and fees) from 30 companies. The largest payer was Novo Nordisk Inc with $508.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 23 | $508 |
| Lilly USA, LLC LLY | 17 | $439 |
| Amgen Inc. AMGN | 19 | $398 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 16 | $332 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 17 | $260 |
| Tandem Diabetes Care, Inc. TNDM | 4 | $225 |
| Dexcom, Inc. DXCM | 12 | $217 |
| Xeris Pharmaceuticals, Inc. | 10 | $216 |
| Ascendis Pharma Endocrinology Inc ASND | 9 | $198 |
| Mannkind Corporation MNKD | 7 | $181 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.